Table of contents


Please note that this product was withdrawn from the Community Register of designated orphan medicinal products in September 2012 on request of the sponsor.

On 9 July 2003, orphan designation (EU/3/03/155) was granted by the European Commission to Cell Control Biomedical Laboratories AG, Germany, for murine anti-idiotypic antibody against OC125 antibody against CA125 antigen (ACA125) for the treatment of ovarian cancer.

The sponsorship was transferred to Menarini Ricerche S.p.A. in December 2004.

For a list of the administrative updates to this public summary of opinion please refer to the PDF document below.

Key facts

Active substance
Murine anti-idiotypic antibody against OC125 antibody against CA125 antigen
Disease / condition
Treatment of ovarian cancer
Date of first decision
EU designation number

Sponsor's contact details

Menarini Ricerche S.p.A.
Via Tito Speri 10
00040 Pomezia (Roma)
Tel: +39 05 55 68 03 13
Fax +39 05 55 68 09 95 4

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.

How useful was this page?

Add your rating